ESTRO PT 2018

My distinguished opponent at ESTRO Particle Therapy Course 2017

Toxicity reduction by protons (retrospective analysis)

NSCLC treated with radiation therapy + chemotherapy at M.D. Anderson (1,2)

3D CRT

IMRT

Protons

Dose

63 Gy

63 Gy

74 CGE

% patients stage IIIA-B2 2

87%

91%

87%

Toxicity Esophagitis – G3+

18%

44%

5%

Pneumonitis – G3+

30%

9%

2%

(1) Samir Sejpal et al., “Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancer,” Cancer e-publication ahead of print (January 24, 2011): 1- 10 (2) Retrospective analysis. In lieu of selection criteria, percentage of patients with Stage IIIA-IIIB were summarized Note: Grade 3 and higher toxicities result in significant medical intervention including hospitalization to manage adverse side effects` Pubmed: Komaki lung cancer proton -> more than 20 publications since 2010

9